ArticleFrontiers in oncology2025

MYO19 is associated with tumor progression, immune evasion, ferroptosis-related signatures in lung squamous cell carcinoma.

Fang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.